Market Research Report
Germany Biomaterials Market Forecast 2021-2026
|Germany Biomaterials Market Forecast 2021-2026|
Published: November 22, 2021
Content info: 132 Pages
Delivery time: 2-3 business days
The Germany biomaterials market is evaluated to record a CAGR of 13.82% over the estimated years. The country's market growth is fueled by key aspects such as notable research and development advancements within the avenue of tissue engineering as well as biomaterials, the presence of well-established players, and the growing demand from the medical devices sector. While the base year considered for the market studied is 2020, the forecasted period is from 2021 to 2026.
German research and development in the arena of biomaterials and tissue engineering occupy a dominant position in international comparison. In this regard, Germany and the United Kingdom represent the key geographic hubs of commercial regenerative medicine activity. Moreover, some of the renowned medical device manufacturers are located in the country, with leading firms across the world conducting business in Germany.
As a prime player in the country, Botiss manufactures regenerative biomaterials acquired from xenografts, collagen, allografts, and synthetic materials for a broad range of dental and bone grafts for surgical applications. The company is also investigating the interaction between biomaterials and stem cells and/or signaling proteins, paving the way for new approaches for the development of innovative products and technologies. The increasing demand for biocompatible personalized treatment, as well as the growing research and development in the field of biomaterials, are set to augment the demand for biomaterials in Germany. Therefore, these factors are expected to drive the country's market growth during the forecasting years.
Leading companies operating in the market are BASF SE, Covestro AG, Evonik Industries, etc.